N@N

Robyn Karnauskas Reiterated (ABBV) at Strong Buy with Increased Target to $210 on, Jul 26th, 2024

^{Published on 2024-10-28 12:48:55 - WOPRAI, Robyn Karnauskas}
 

Robyn Karnauskas of Truist Securities, Reiterated "AbbVie Inc." (ABBV) at Strong Buy with Increased Target from $195 to $210 on, Jul 26th, 2024.

Robyn has made no other calls on ABBV in the last 4 months.

There are 4 other peers that have a rating on ABBV. Out of the 4 peers that are also analyzing ABBV, 0 agree with Robyn's Rating of Hold.

These are the ratings of the 4 analyists that currently disagree with Robyn

---

• Evan David Seigerman of "BMO Capital" Maintained at Buy with Increased Target to $214 on, Friday, July 19th, 2024
• Terence Flynn of "Morgan Stanley" Maintained at Buy with Increased Target to $196 on, Thursday, July 11th, 2024
• Christopher Raymond of "Piper Sandler" Maintained at Buy and Held Target at $190 on, Tuesday, July 2nd, 2024
• Rajesh Kumar of "HSBC" Upgraded from Hold to Strong Buy and Held Target at $185 on, Wednesday, June 5th, 2024

Contributing Sources

---